![David Sandoval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Sandoval
Compliance Officer at
MILESTONE PHARMACEUTICALS INC.
Net worth: 78 989 $ as of 30/06/2026
Profile
David Sandoval currently serves as Chief Compliance Officer & General Counsel at Milestone Pharmaceuticals, Inc. since 2026.
Memberships include the New York State Bar Association and the New Jersey State Bar Association.
Former roles include Senior VP-Legal & Deputy General Counsel at MaxCyte, Inc. from 2023 to 2024, Chief Legal & Compliance Officer at Leadiant Biosciences, Inc. from 2010 to 2023, and Assistant General Counsel at Enzon Pharmaceuticals, Inc. from 2007 to 2010.
Education includes graduate studies at New York University School of Law and undergraduate studies at Cornell University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MAXCYTE, INC. 0.06% | 18/03/2025 | 64,219 ( 0.06% ) | 78 989 $ | 30/06/2026 |
David Sandoval active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Compliance Officer | 10/02/2026 |
New York State Bar Association
 New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
New Jersey State Bar Association
 New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Former positions of David Sandoval
| Companies | Position | End |
|---|---|---|
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Compliance Officer | 01/11/2023 |
Enzon Pharmaceuticals, Inc.
 Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 01/01/2010 |
| MAXCYTE, INC. | General Counsel | - |
Training of David Sandoval
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
MaxCyte, Inc.
 MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New Jersey State Bar Association
New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New York University School of Law
 New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Sandoval
